How should a catheter-related bloodstream infection (CRBSI) be managed?

Management of Catheter-Related Bloodstream Infection (CRBSI)

Remove the catheter immediately and initiate appropriate systemic antibiotics based on the pathogen and clinical severity. This is the cornerstone of CRBSI management for most cases, particularly for short-term catheters and high-risk pathogens 1.

Initial Assessment and Diagnosis

Obtain two sets of blood cultures: one from a peripheral vein and one through the catheter 1. Label each bottle with the anatomic site to enable differential time to positivity (DTP) analysis, which can confirm catheter-related infection when catheter-drawn cultures turn positive ≥2 hours before peripheral cultures 1.

For patients who are seriously ill (hypotension, organ failure, sepsis), remove the catheter immediately and culture the tip 1.

For mildly to moderately ill patients without identified alternative infection source, obtain blood cultures and consider empirical antimicrobial therapy while awaiting results 1.

Empirical Antibiotic Therapy

Start empirical therapy based on severity and local epidemiology:

• Vancomycin for gram-positive coverage in settings with high methicillin-resistant Staphylococcus aureus (MRSA) prevalence; if local MRSA isolates have vancomycin MIC >2 μg/mL, use daptomycin instead 1
• Do not use linezolid for empirical therapy 1
• Add gram-negative coverage (fourth-generation cephalosporin, carbapenem, or β-lactam/β-lactamase combination ± aminoglycoside) based on local susceptibility patterns 1
• For femoral catheters in critically ill patients, add empirical antifungal coverage (echinocandin or fluconazole) 1
• For neutropenic or severely septic patients, use combination therapy for multidrug-resistant gram-negative bacilli including Pseudomonas aeruginosa 1

Pathogen-Specific Management

Staphylococcus aureus

• Always remove the catheter 1
• Treat for 4-6 weeks with appropriate antibiotics 1
• Switch to cefazolin if methicillin-susceptible (not vancomycin) 1
• Obtain transesophageal echocardiogram (TEE) 5-7 days after bacteremia onset to exclude endocarditis 1
• Shorter therapy (≥14 days) is acceptable ONLY if: non-diabetic, non-immunosuppressed, catheter removed, no prosthetic devices, TEE negative for endocarditis, fever/bacteremia resolve within 72 hours, and no metastatic infection 1

Coagulase-Negative Staphylococci

• Remove catheter and treat for 5-7 days 1
• If catheter retained (long-term catheters only), treat for 10-14 days with antibiotic lock therapy 1
• Alternative: For uncomplicated cases with no intravascular hardware, observe without antibiotics after catheter removal if repeat blood cultures are negative 1
• Exception: Treat Staphylococcus lugdunensis like S. aureus (4-6 weeks) 1

Enterococcus Species

• Remove catheter and treat for 7-14 days 1
• For vancomycin-resistant enterococci in hemodialysis patients: daptomycin 6 mg/kg after each dialysis or linezolid 600 mg every 12 hours 1

Gram-Negative Bacilli

• Remove catheter and treat for 7-14 days 1
• For hemodialysis catheters with non-Pseudomonas gram-negatives or coagulase-negative staphylococci: may attempt catheter salvage with guidewire exchange if symptoms resolve within 2-3 days and no metastatic infection 1

Candida Species

• Always remove the catheter 1
• Treat with antifungal therapy for 14 days after first negative blood culture 1
• Use echinocandin as first-line; fluconazole acceptable only if no azole exposure in past 3 months and low risk of C. krusei or C. glabrata 1

Extended Therapy Indications

Treat for 4-6 weeks if any of the following:

• Persistent bacteremia/fungemia >72 hours after catheter removal 1
• Endocarditis 1
• Suppurative thrombophlebitis 1
• Osteomyelitis in children 1

Treat for 6-8 weeks for osteomyelitis in adults 1

Catheter Salvage with Antibiotic Lock Therapy

Use antibiotic lock therapy only for long-term catheters without exit site or tunnel infection when catheter retention is essential 1:

• Never use lock therapy alone—always combine with systemic antibiotics for 10-14 days 1
• Do not attempt salvage for S. aureus or Candida species—remove catheter 1
• Antibiotic concentration must be ≥1000× the MIC (e.g., vancomycin 5 mg/mL) 1
• Dwell time should not exceed 48 hours; preferably reinstall every 24 hours 1
• For hemodialysis catheters, renew lock solution after each dialysis session 1

Hemodialysis-Specific Considerations

• Obtain peripheral blood cultures from vessels not intended for future fistula creation (e.g., hand veins) 1
• Empirical therapy: vancomycin plus gram-negative coverage (third-generation cephalosporin, carbapenem, or β-lactam/β-lactamase) 1
• Always remove catheter for S. aureus, Pseudomonas, or Candida CRBSI 1
• For other pathogens: may attempt guidewire exchange if symptoms resolve within 2-3 days and no metastatic infection 1
• Cefazolin dosing: 20 mg/kg (actual body weight) rounded to nearest 500-mg increment after dialysis 1
• Obtain surveillance blood cultures 1 week after completing antibiotics if catheter retained 1

Common Pitfalls

• Do not use vancomycin for methicillin-susceptible staphylococci—switch to cefazolin or other β-lactam 1
• Do not attempt catheter salvage for S. aureus or Candida—removal is mandatory except in extraordinary circumstances 1
• Do not give antibiotics alone without catheter removal for hemodialysis CRBSI—this leads to 5-fold higher treatment failure 1
• Do not skip TEE for S. aureus bacteremia if considering shortened therapy 1
• Do not delay catheter removal if bacteremia/fungemia persists >72 hours despite appropriate antibiotics 1